BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17388803)

  • 1. The intrinsic pathway of coagulation: a target for treating thromboembolic disease?
    Gailani D; Renné T
    J Thromb Haemost; 2007 Jun; 5(6):1106-12. PubMed ID: 17388803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intrinsic pathway of coagulation is essential for thrombus stability in mice.
    Renné T; Nieswandt B; Gailani D
    Blood Cells Mol Dis; 2006; 36(2):148-51. PubMed ID: 16466946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
    Cheng Q; Tucker EI; Pine MS; Sisler I; Matafonov A; Sun MF; White-Adams TC; Smith SA; Hanson SR; McCarty OJ; Renné T; Gruber A; Gailani D
    Blood; 2010 Nov; 116(19):3981-9. PubMed ID: 20634381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective thrombus formation in mice lacking coagulation factor XII.
    Renné T; Pozgajová M; Grüner S; Schuh K; Pauer HU; Burfeind P; Gailani D; Nieswandt B
    J Exp Med; 2005 Jul; 202(2):271-81. PubMed ID: 16009717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Deficiency of Intrinsic Coagulation Factors XI and XII on Ex Vivo Thrombus Formation and Clot Lysis.
    Govers-Riemslag JWP; Konings J; Cosemans JMEM; van Geffen JP; de Laat B; Heemskerk JWM; Dargaud Y; Ten Cate H
    TH Open; 2019 Jul; 3(3):e273-e285. PubMed ID: 31511847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX.
    Visser M; van Oerle R; Ten Cate H; Laux V; Mackman N; Heitmeier S; Spronk HMH
    Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):103-111. PubMed ID: 31766871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation.
    Stroo I; Zeerleder S; Ding C; Luken BM; Roelofs JJTH; de Boer OJ; Meijers JCM; Castellino FJ; van 't Veer C; van der Poll T
    Thromb Haemost; 2017 Jul; 117(8):1601-1614. PubMed ID: 28492700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
    Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
    J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
    Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
    Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulation.
    Wan J; Tanratana P; Roest M; Gruber A; Pawlinski R; Wolberg AS; Mackman N; Grover SP
    Blood Adv; 2023 May; 7(9):1915-1925. PubMed ID: 36583671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XI and XII as antithrombotic targets.
    Müller F; Gailani D; Renné T
    Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model-dependent contributions of FXII and FXI to venous thrombosis in mice.
    Grover SP; Olson TM; Cooley BC; Mackman N
    J Thromb Haemost; 2020 Nov; 18(11):2899-2909. PubMed ID: 33094904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation factor XI as a novel target for antithrombotic treatment.
    Löwenberg EC; Meijers JC; Monia BP; Levi M
    J Thromb Haemost; 2010 Nov; 8(11):2349-57. PubMed ID: 20727068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laminin promotes coagulation and thrombus formation in a factor XII-dependent manner.
    White-Adams TC; Berny MA; Patel IA; Tucker EI; Gailani D; Gruber A; McCarty OJ
    J Thromb Haemost; 2010 Jun; 8(6):1295-301. PubMed ID: 20796202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rebirth of the contact pathway: a new therapeutic target.
    Srivastava P; Gailani D
    Curr Opin Hematol; 2020 Sep; 27(5):311-319. PubMed ID: 32740037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
    Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
    J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coming soon to a pharmacy near you? FXI and FXII inhibitors to prevent or treat thromboembolism.
    Cohen O; Ageno W
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):495-505. PubMed ID: 36485148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway.
    He R; Xiong S; He X; Liu F; Han J; Li J; He S
    Thromb Haemost; 2001 Jun; 85(6):1055-9. PubMed ID: 11434684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hemostatic role of factor XI.
    Puy C; Rigg RA; McCarty OJ
    Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.